AON (AONC): Rata-rata rega prakiraan

Simbol lan logo merek AON (AONC)

Current price action for American Oncology Network (AONC) reflects market expectations as the company implements RPA bots to digitize billing and card accounting, where the indicator stands at 0.00. The business relies on environmental sustainability by eliminating paper and ensuring safe waste disposal. The development model is based on creating a unified infrastructure for small centers, helping them compete effectively against industry behemoths.

AONC (American Oncology Network Inc) riwayat Prakiraan konsensus analis saka 21.02.2024 nganti 04.08.2024

Rincian analitis perusahaan American Oncology Network (AONC)

Indikator analitis utama aoncology.com (AONC):
Analisis fundamental perusahaan:American Oncology Network Inc (AONC)
Produk asli American Oncology Network

Finding a balance between operational risks and return on capital at American Oncology Network (AONC) requires an analysis of the integration of AI diagnostics and the pharmacy hub into a single B2B circuit. This consensus target chart aggregates average investment bank estimates, reflecting the business's fundamental value through expected cash flows, which allows investors to separate market noise from the long-term sustainability of this medical ecosystem.

Perusahaan pesaing

Prakiraan konsensus analis beigene.com (ONC)|Bagan rega target Halozyme HALO|Revolution Medicines Inc (RVMD) - Rata-rata rega prakiraan|AAPG - Bagan rega target|CGON (CG Oncology Therapeutics) - Prakiraan gabungan firma investasi|URGN: Prakiraan konsensus analis|Target konsensus bicara.com|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Prakiraan konsensus analis VERU|Prakiraan konsensus analis tempesttx.com (TPST)|Bagan rega target Xilio Therapeutics XLO|RENB - Target konsensus|Mural Bio - Prakiraan konsensus analis|Rata-rata rega prakiraan Kairos Pharma Ltd|onkuretherapeutics.com (OKUR) - Bagan rega target|CytoMed Therapeutics Limited - Konsensus nilai wajar|CRIS (Curis Inc.) - Prakiraan konsensus analis|Apollomics Corp (APLM) - Target median analis|Prakiraan konsensus analis THAR|Target konsensus advanbiomed.com ADVB|Prakiraan konsensus analis GNPX (Genprex, Inc.)|Prakiraan konsensus analis Calidi Biotherapeutics Inc. CLDI|SBFM - Bagan rega target|XBIO (Xenetic Biosciences) - Prakiraan gabungan firma investasi|SLRX (Salarius) - Target konsensus|Kitov Pharma - Konsensus nilai wajar|Bagan rega target BeiGene, Ltd.|Rata-rata rega prakiraan checkpointtx.com CKPT|Bagan rega target Elevation Oncology, Inc. (ELEV)|icadmed.com - Prakiraan gabungan firma investasi|Prakiraan konsensus analis IKNA (Ikena Oncology)|NTBL - Target konsensus|VIRX - Bagan rega target|Rata-rata rega prakiraan morphosys.com|NAYA Biosciences Inc. (NAYA) - Bagan rega target|AAPGV (Ascentage Pharma Group International) - Bagan rega target